Microvessel density and p53 overexpression in young women with breast cancer

A case-control study

B. Kalfon, Susan A. Fineberg, Y. Gu, K. Anand, A. Dalal, J. Jones, Joseph A. Sparano

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Several reports have indicated that young women (less than 40 years of age) with breast cancer have a worse prognosis than older women. We performed a case-control study in order to confirm this observation and to determine whether this was attributable to increased microvessel density (MVD) or p53 expression. Twenty-six young women (cases) with stage I-III breast cancer that had adequate paraffin-embedded archival tissue were identified by the Montefiore Medical Center Tumor Registry over a 24-year period. For each case, two or three control subjects at least 40 years of age or older were selected from the registry and matched for nodal status and tumor size. Immunohistochemistry was performed for MVD and p53 overexpression. A Cox proportional hazard model was performed to examine the influence of age, MVD, p53 overexpression, and recognized prognostic factors on disease-free and overall survival. There were 26 cases (median age, 36 years) and 72 controls (median age, 64 years). The groups were well matched for known prognostic variables. There was no significant difference in p53 overexpression or MVD in the cases and controls. In multivariate analysis, the only features associated with an increased risk of recurrence included young age (hazard ratio [HR] = 2.49; 95% confidence interval [CI]: 1.18-5.25; P = 0.02) and positive lymph nodes (HR =2.44; 95% CI: 1.12-5.30; P = 0.02). We have confirmed previous reports demonstrating a worse prognosis for women younger than 40 years with invasive breast cancer but found no correlation between young age and MVD or p53 overexpression when adjusted for other variables.

Original languageEnglish (US)
Pages (from-to)67-72
Number of pages6
JournalClinical Breast Cancer
Volume2
Issue number1
StatePublished - 2001

Fingerprint

Microvessels
Case-Control Studies
Breast Neoplasms
Registries
Confidence Intervals
Proportional Hazards Models
Paraffin
Disease-Free Survival
Neoplasms
Multivariate Analysis
Lymph Nodes
Immunohistochemistry
Recurrence

Keywords

  • Breast cancer
  • Microvessel density
  • P53 overexpression
  • Young age

ASJC Scopus subject areas

  • Cancer Research

Cite this

Microvessel density and p53 overexpression in young women with breast cancer : A case-control study. / Kalfon, B.; Fineberg, Susan A.; Gu, Y.; Anand, K.; Dalal, A.; Jones, J.; Sparano, Joseph A.

In: Clinical Breast Cancer, Vol. 2, No. 1, 2001, p. 67-72.

Research output: Contribution to journalArticle

@article{57a634c80ad94f8480b30b0d06f5729d,
title = "Microvessel density and p53 overexpression in young women with breast cancer: A case-control study",
abstract = "Several reports have indicated that young women (less than 40 years of age) with breast cancer have a worse prognosis than older women. We performed a case-control study in order to confirm this observation and to determine whether this was attributable to increased microvessel density (MVD) or p53 expression. Twenty-six young women (cases) with stage I-III breast cancer that had adequate paraffin-embedded archival tissue were identified by the Montefiore Medical Center Tumor Registry over a 24-year period. For each case, two or three control subjects at least 40 years of age or older were selected from the registry and matched for nodal status and tumor size. Immunohistochemistry was performed for MVD and p53 overexpression. A Cox proportional hazard model was performed to examine the influence of age, MVD, p53 overexpression, and recognized prognostic factors on disease-free and overall survival. There were 26 cases (median age, 36 years) and 72 controls (median age, 64 years). The groups were well matched for known prognostic variables. There was no significant difference in p53 overexpression or MVD in the cases and controls. In multivariate analysis, the only features associated with an increased risk of recurrence included young age (hazard ratio [HR] = 2.49; 95{\%} confidence interval [CI]: 1.18-5.25; P = 0.02) and positive lymph nodes (HR =2.44; 95{\%} CI: 1.12-5.30; P = 0.02). We have confirmed previous reports demonstrating a worse prognosis for women younger than 40 years with invasive breast cancer but found no correlation between young age and MVD or p53 overexpression when adjusted for other variables.",
keywords = "Breast cancer, Microvessel density, P53 overexpression, Young age",
author = "B. Kalfon and Fineberg, {Susan A.} and Y. Gu and K. Anand and A. Dalal and J. Jones and Sparano, {Joseph A.}",
year = "2001",
language = "English (US)",
volume = "2",
pages = "67--72",
journal = "Clinical Breast Cancer",
issn = "1526-8209",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Microvessel density and p53 overexpression in young women with breast cancer

T2 - A case-control study

AU - Kalfon, B.

AU - Fineberg, Susan A.

AU - Gu, Y.

AU - Anand, K.

AU - Dalal, A.

AU - Jones, J.

AU - Sparano, Joseph A.

PY - 2001

Y1 - 2001

N2 - Several reports have indicated that young women (less than 40 years of age) with breast cancer have a worse prognosis than older women. We performed a case-control study in order to confirm this observation and to determine whether this was attributable to increased microvessel density (MVD) or p53 expression. Twenty-six young women (cases) with stage I-III breast cancer that had adequate paraffin-embedded archival tissue were identified by the Montefiore Medical Center Tumor Registry over a 24-year period. For each case, two or three control subjects at least 40 years of age or older were selected from the registry and matched for nodal status and tumor size. Immunohistochemistry was performed for MVD and p53 overexpression. A Cox proportional hazard model was performed to examine the influence of age, MVD, p53 overexpression, and recognized prognostic factors on disease-free and overall survival. There were 26 cases (median age, 36 years) and 72 controls (median age, 64 years). The groups were well matched for known prognostic variables. There was no significant difference in p53 overexpression or MVD in the cases and controls. In multivariate analysis, the only features associated with an increased risk of recurrence included young age (hazard ratio [HR] = 2.49; 95% confidence interval [CI]: 1.18-5.25; P = 0.02) and positive lymph nodes (HR =2.44; 95% CI: 1.12-5.30; P = 0.02). We have confirmed previous reports demonstrating a worse prognosis for women younger than 40 years with invasive breast cancer but found no correlation between young age and MVD or p53 overexpression when adjusted for other variables.

AB - Several reports have indicated that young women (less than 40 years of age) with breast cancer have a worse prognosis than older women. We performed a case-control study in order to confirm this observation and to determine whether this was attributable to increased microvessel density (MVD) or p53 expression. Twenty-six young women (cases) with stage I-III breast cancer that had adequate paraffin-embedded archival tissue were identified by the Montefiore Medical Center Tumor Registry over a 24-year period. For each case, two or three control subjects at least 40 years of age or older were selected from the registry and matched for nodal status and tumor size. Immunohistochemistry was performed for MVD and p53 overexpression. A Cox proportional hazard model was performed to examine the influence of age, MVD, p53 overexpression, and recognized prognostic factors on disease-free and overall survival. There were 26 cases (median age, 36 years) and 72 controls (median age, 64 years). The groups were well matched for known prognostic variables. There was no significant difference in p53 overexpression or MVD in the cases and controls. In multivariate analysis, the only features associated with an increased risk of recurrence included young age (hazard ratio [HR] = 2.49; 95% confidence interval [CI]: 1.18-5.25; P = 0.02) and positive lymph nodes (HR =2.44; 95% CI: 1.12-5.30; P = 0.02). We have confirmed previous reports demonstrating a worse prognosis for women younger than 40 years with invasive breast cancer but found no correlation between young age and MVD or p53 overexpression when adjusted for other variables.

KW - Breast cancer

KW - Microvessel density

KW - P53 overexpression

KW - Young age

UR - http://www.scopus.com/inward/record.url?scp=0035012197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035012197&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 67

EP - 72

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

SN - 1526-8209

IS - 1

ER -